24 series
Export
<<< of 2>>>
Accession Title Series type(s) Organism(s) Samples GDS Supplementary Contact Release date
Remove filtersFilter Remove filterMatthew Meier
GSE241067
Unlocking the power of transcriptomic biomarkers in qualitative and quantitative genotoxicity assessment of chemicals I
90 Matthew Meier Mar 27, 2024
GSE241068
Unlocking the power of transcriptomic biomarkers in qualitative and quantitative genotoxicity assessment of chemicals II
71 Matthew Meier Mar 27, 2024
GSE241069
Unlocking the power of transcriptomic biomarkers in qualitative and quantitative genotoxicity assessment of chemicals
161 Matthew Meier Mar 27, 2024
GSE241995
Toxicological Mechanisms and Potencies of Organophosphate Esters in KGN Human Ovarian Granulosa Cells as Revealed by High-throughput Transcriptomics
162 Matthew Meier Nov 07, 2023
GSE144797
DNA methylation in Syrian hamster female fetal cells (gestation day 13.5) exposed in vitro to 5-aza-2’deoxycytidine (5aCdR)
11 Matthew Meier Feb 10, 2023
GSE144799
Chronology of DNA methylation changes through transformation stage leading to senescence by-pass in Syrian hamster fetal primary cells exposed to benzo[a]pyrene
24 Matthew Meier Feb 10, 2023
GSE218911
Finding genetic loci that are sensitive to demethylation to assist in the development of DNA methylation-based in vitro assay for the identification of carcinogens
34 Matthew Meier Feb 10, 2023
GSE220238
DNA methylation changes from primary cultures through senescence-bypass in Syrian hamster fetal cells initially exposed to benzo[a]pyrene
69 Matthew Meier Feb 10, 2023
GSE144793
Impact of chronic low dose dioxin exposure during pregnancy on the mouse pancreas from both dams and their male and female offspring
22 Matthew Meier Feb 04, 2023
GSE213454
Application of a New Approach Methodology (NAM)-based Strategy for Genotoxicity Assessment of Data-poor Compounds
276 Matthew Meier Nov 15, 2022
GSE211183
In vitro transcriptomic analyses reveal pathway perturbations, estrogenic activities, and potencies of data-poor BPA alternative chemicals
768 Matthew Meier Aug 18, 2022
GSE196369
Toxicity Testing in the 21st Century: An Integrated Approach to Genetic Safety Testing using the TGx-DDI Genomic Biomarker and High-Throughput CometChip® [NanoString]
96 Matthew Meier Aug 02, 2022
GSE196372
Toxicity Testing in the 21st Century: An Integrated Approach to Genetic Safety Testing using the TGx-DDI Genomic Biomarker and High-Throughput CometChip® [Sequencing]
96 Matthew Meier Aug 02, 2022
GSE196373
Toxicity Testing in the 21st Century: An Integrated Approach to Genetic Safety Testing using the TGx-DDI Genomic Biomarker and High-Throughput CometChip®
192 Matthew Meier Aug 02, 2022
GSE141144
Transcriptional analysis of the effects of early life exposure to fluoxetine on telencephalon and hypothalamus in SR4G transgenic zebrafish larvae and adults
72 Matthew Meier Apr 26, 2022
GSE145239
High-throughput transcriptomics assessment of 24 per- and polyfluoroalkyl substances (PFAS) in human liver spheroids
1201 Matthew Meier Nov 08, 2021
GSE171360
CometChip® and TempO-Seq®: A high-throughput 96-well platform to measure and classify DNA damaging agents in human HepaRG™ Cells [HCC3]
288 Matthew Meier Jul 21, 2021
GSE153320
Transcriptomics and relative potency assessments using Bench Mark Dose  of Bisphenol A, Bisphenol S, Bisphenol F, and 3,3',5,5'-Tetrabromobisphenol A in H9 human embryonic stem cells
80 Matthew Meier Jul 19, 2021
GSE164478
Development of a transcriptomic biomarker to detect histone deacetylase inhibitors (HDACi) in TK6 cells
128 Matthew Meier Apr 14, 2021
GSE144775
Development and application of a high-throughput gene expression profiling of per- and polyfluoroalkyl substances (PFAS) in primary liver human spheroids to inform read-across
607 Matthew Meier Dec 22, 2020